Home » Topics » Regulatory » Patents

Patents
RSS

Merck KGaA reports two new series of ET antagonists

Nov. 3, 1997

Oxazolidinone antibacterial agents prepared at P&U

Nov. 3, 1997

New tumor contrast agents disclosed

Oct. 31, 1997

New immunomodulators for treating rheumatoid arthritis

Oct. 31, 1997

Antimicrobial GE-2270 derivatives from Biosearch

Oct. 31, 1997

HMR discloses azasteroids for estrogen/androgen-mediated disorders

Oct. 31, 1997

BE-52440A and BE-52440B: novel antitumor antibiotics reported in patent literature

Oct. 31, 1997

Roussel Morishita reports antiulcer agents with a novel mechanism of action

Oct. 31, 1997

Ortho discloses peptide serine protease inhibitors

Oct. 30, 1997

HMR reports dual H1/NK1 receptor antagonists

Oct. 30, 1997

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...